The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Vinblastinesulphate-Global Market Insights and Sales Trends 2025
Synopsis
Vinblastinesulphate (CAS 143-67-9) is a white or light yellow amorphous power, which is easily soluble in water. Vinblastine belongs to the group of cancer-fighting medications known as antineoplastics. Vinblastine is used alone or in combination with other antineoplastic medications to treat many different types of cancer including Hodgkin's disease, non-Hodgkin's lymphoma (cancer of the lymph cells), Kaposi's sarcoma, breast cancer, and testicular cancer. It kills cancer cells by interfering with the genetic material DNA, which is necessary for their growth and reproduction.
The global Vinblastinesulphate market size is expected to reach US$ 24 million by 2029, growing at a CAGR of 1.1% from 2023 to 2029. The market is mainly driven by the significant applications of Vinblastinesulphate in various end use industries. The expanding demands from the Lymphoma, Lung Cancer, Breast & Ovarian Cancer and Leukemia, are propelling Vinblastinesulphate market. >98% Vinblastinesulphate, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 97-98% Vinblastinesulphate segment is estimated at % CAGR for the next seven-year period.
Global Vinblastinesulphate (CAS 143-67-9) key players include Guangzhou Hanfang Pharmaceutical, Hainan Vinca Biological Medicine Technology, Guangzhou Person Pharmaceutical, Hainan Yueyang Biotechnology, etc. Global top four manufacturers hold a share about 60%.
China is the largest market, with a share about 40%, followed by Europe and USA, have a share over 40 percent.
In terms of product, 97-98% Vinblastinesulphate is the largest segment, with a share about 60%. And in terms of application, the largest application is Lymphoma, followed by Lung Cancer, Breast & Ovarian Cancer, Leukemia, ect.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Vinblastinesulphate, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Vinblastinesulphate market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Vinblastinesulphate market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Vinblastinesulphate sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Vinblastinesulphate covered in this report include Guangzhou Hanfang Pharmaceutical, Hainan Vinca Biological Medicine Technology, Guangzhou Person Pharmaceutical, Hainan Yueyang Biotechnology, Hubei Honch Pharmaceutical, Fine Chemicals Corporation, Hengtengfu Biological Products and Vinkem, etc.
The global Vinblastinesulphate market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Guangzhou Hanfang Pharmaceutical
Hainan Vinca Biological Medicine Technology
Guangzhou Person Pharmaceutical
Hainan Yueyang Biotechnology
Hubei Honch Pharmaceutical
Fine Chemicals Corporation
Hengtengfu Biological Products
Vinkem
Global Vinblastinesulphate market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Vinblastinesulphate market, Segment by Type:
>98% Vinblastinesulphate
97-98% Vinblastinesulphate
Other
Global Vinblastinesulphate market, by Application
Lymphoma
Lung Cancer
Breast & Ovarian Cancer
Leukemia
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Vinblastinesulphate manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Vinblastinesulphate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Vinblastinesulphate (CAS 143-67-9) is a white or light yellow amorphous power, which is easily soluble in water. Vinblastine belongs to the group of cancer-fighting medications known as antineoplastics. Vinblastine is used alone or in combination with other antineoplastic medications to treat many different types of cancer including Hodgkin's disease, non-Hodgkin's lymphoma (cancer of the lymph cells), Kaposi's sarcoma, breast cancer, and testicular cancer. It kills cancer cells by interfering with the genetic material DNA, which is necessary for their growth and reproduction.
The global Vinblastinesulphate market size is expected to reach US$ 24 million by 2029, growing at a CAGR of 1.1% from 2023 to 2029. The market is mainly driven by the significant applications of Vinblastinesulphate in various end use industries. The expanding demands from the Lymphoma, Lung Cancer, Breast & Ovarian Cancer and Leukemia, are propelling Vinblastinesulphate market. >98% Vinblastinesulphate, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 97-98% Vinblastinesulphate segment is estimated at % CAGR for the next seven-year period.
Global Vinblastinesulphate (CAS 143-67-9) key players include Guangzhou Hanfang Pharmaceutical, Hainan Vinca Biological Medicine Technology, Guangzhou Person Pharmaceutical, Hainan Yueyang Biotechnology, etc. Global top four manufacturers hold a share about 60%.
China is the largest market, with a share about 40%, followed by Europe and USA, have a share over 40 percent.
In terms of product, 97-98% Vinblastinesulphate is the largest segment, with a share about 60%. And in terms of application, the largest application is Lymphoma, followed by Lung Cancer, Breast & Ovarian Cancer, Leukemia, ect.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Vinblastinesulphate, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Vinblastinesulphate market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Vinblastinesulphate market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Vinblastinesulphate sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Vinblastinesulphate covered in this report include Guangzhou Hanfang Pharmaceutical, Hainan Vinca Biological Medicine Technology, Guangzhou Person Pharmaceutical, Hainan Yueyang Biotechnology, Hubei Honch Pharmaceutical, Fine Chemicals Corporation, Hengtengfu Biological Products and Vinkem, etc.
The global Vinblastinesulphate market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Guangzhou Hanfang Pharmaceutical
Hainan Vinca Biological Medicine Technology
Guangzhou Person Pharmaceutical
Hainan Yueyang Biotechnology
Hubei Honch Pharmaceutical
Fine Chemicals Corporation
Hengtengfu Biological Products
Vinkem
Global Vinblastinesulphate market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Vinblastinesulphate market, Segment by Type:
>98% Vinblastinesulphate
97-98% Vinblastinesulphate
Other
Global Vinblastinesulphate market, by Application
Lymphoma
Lung Cancer
Breast & Ovarian Cancer
Leukemia
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Vinblastinesulphate manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Vinblastinesulphate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Vinblastinesulphate Market Overview
1.1 Vinblastinesulphate Product Overview
1.2 Vinblastinesulphate Market Segment by Type
1.2.1 >98% Vinblastinesulphate
1.2.2 97-98% Vinblastinesulphate
1.2.3 Other
1.3 Global Vinblastinesulphate Market Size by Type
1.3.1 Global Vinblastinesulphate Market Size Overview by Type (2018-2029)
1.3.2 Global Vinblastinesulphate Historic Market Size Review by Type (2018-2023)
1.3.3 Global Vinblastinesulphate Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Vinblastinesulphate Sales Breakdown by Type (2018-2023)
1.4.2 Europe Vinblastinesulphate Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Vinblastinesulphate Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Vinblastinesulphate Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Vinblastinesulphate Sales Breakdown by Type (2018-2023)
2 Global Vinblastinesulphate Market Competition by Company
2.1 Global Top Players by Vinblastinesulphate Sales (2018-2023)
2.2 Global Top Players by Vinblastinesulphate Revenue (2018-2023)
2.3 Global Top Players by Vinblastinesulphate Price (2018-2023)
2.4 Global Top Manufacturers Vinblastinesulphate Manufacturing Base Distribution, Sales Area, Product Type
2.5 Vinblastinesulphate Market Competitive Situation and Trends
2.5.1 Vinblastinesulphate Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Vinblastinesulphate Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Vinblastinesulphate as of 2022)
2.7 Date of Key Manufacturers Enter into Vinblastinesulphate Market
2.8 Key Manufacturers Vinblastinesulphate Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Vinblastinesulphate Status and Outlook by Region
3.1 Global Vinblastinesulphate Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Vinblastinesulphate Historic Market Size by Region
3.2.1 Global Vinblastinesulphate Sales in Volume by Region (2018-2023)
3.2.2 Global Vinblastinesulphate Sales in Value by Region (2018-2023)
3.2.3 Global Vinblastinesulphate Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Vinblastinesulphate Forecasted Market Size by Region
3.3.1 Global Vinblastinesulphate Sales in Volume by Region (2024-2029)
3.3.2 Global Vinblastinesulphate Sales in Value by Region (2024-2029)
3.3.3 Global Vinblastinesulphate Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Vinblastinesulphate by Application
4.1 Vinblastinesulphate Market Segment by Application
4.1.1 Lymphoma
4.1.2 Lung Cancer
4.1.3 Breast & Ovarian Cancer
4.1.4 Leukemia
4.1.5 Other
4.2 Global Vinblastinesulphate Market Size by Application
4.2.1 Global Vinblastinesulphate Market Size Overview by Application (2018-2029)
4.2.2 Global Vinblastinesulphate Historic Market Size Review by Application (2018-2023)
4.2.3 Global Vinblastinesulphate Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Vinblastinesulphate Sales Breakdown by Application (2018-2023)
4.3.2 Europe Vinblastinesulphate Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Vinblastinesulphate Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Vinblastinesulphate Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Vinblastinesulphate Sales Breakdown by Application (2018-2023)
5 North America Vinblastinesulphate by Country
5.1 North America Vinblastinesulphate Historic Market Size by Country
5.1.1 North America Vinblastinesulphate Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Vinblastinesulphate Sales in Volume by Country (2018-2023)
5.1.3 North America Vinblastinesulphate Sales in Value by Country (2018-2023)
5.2 North America Vinblastinesulphate Forecasted Market Size by Country
5.2.1 North America Vinblastinesulphate Sales in Volume by Country (2024-2029)
5.2.2 North America Vinblastinesulphate Sales in Value by Country (2024-2029)
6 Europe Vinblastinesulphate by Country
6.1 Europe Vinblastinesulphate Historic Market Size by Country
6.1.1 Europe Vinblastinesulphate Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Vinblastinesulphate Sales in Volume by Country (2018-2023)
6.1.3 Europe Vinblastinesulphate Sales in Value by Country (2018-2023)
6.2 Europe Vinblastinesulphate Forecasted Market Size by Country
6.2.1 Europe Vinblastinesulphate Sales in Volume by Country (2024-2029)
6.2.2 Europe Vinblastinesulphate Sales in Value by Country (2024-2029)
7 Asia-Pacific Vinblastinesulphate by Region
7.1 Asia-Pacific Vinblastinesulphate Historic Market Size by Region
7.1.1 Asia-Pacific Vinblastinesulphate Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Vinblastinesulphate Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Vinblastinesulphate Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Vinblastinesulphate Forecasted Market Size by Region
7.2.1 Asia-Pacific Vinblastinesulphate Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Vinblastinesulphate Sales in Value by Region (2024-2029)
8 Latin America Vinblastinesulphate by Country
8.1 Latin America Vinblastinesulphate Historic Market Size by Country
8.1.1 Latin America Vinblastinesulphate Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Vinblastinesulphate Sales in Volume by Country (2018-2023)
8.1.3 Latin America Vinblastinesulphate Sales in Value by Country (2018-2023)
8.2 Latin America Vinblastinesulphate Forecasted Market Size by Country
8.2.1 Latin America Vinblastinesulphate Sales in Volume by Country (2024-2029)
8.2.2 Latin America Vinblastinesulphate Sales in Value by Country (2024-2029)
9 Middle East and Africa Vinblastinesulphate by Country
9.1 Middle East and Africa Vinblastinesulphate Historic Market Size by Country
9.1.1 Middle East and Africa Vinblastinesulphate Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Vinblastinesulphate Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Vinblastinesulphate Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Vinblastinesulphate Forecasted Market Size by Country
9.2.1 Middle East and Africa Vinblastinesulphate Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Vinblastinesulphate Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Guangzhou Hanfang Pharmaceutical
10.1.1 Guangzhou Hanfang Pharmaceutical Company Information
10.1.2 Guangzhou Hanfang Pharmaceutical Introduction and Business Overview
10.1.3 Guangzhou Hanfang Pharmaceutical Vinblastinesulphate Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Guangzhou Hanfang Pharmaceutical Vinblastinesulphate Products Offered
10.1.5 Guangzhou Hanfang Pharmaceutical Recent Development
10.2 Hainan Vinca Biological Medicine Technology
10.2.1 Hainan Vinca Biological Medicine Technology Company Information
10.2.2 Hainan Vinca Biological Medicine Technology Introduction and Business Overview
10.2.3 Hainan Vinca Biological Medicine Technology Vinblastinesulphate Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Hainan Vinca Biological Medicine Technology Vinblastinesulphate Products Offered
10.2.5 Hainan Vinca Biological Medicine Technology Recent Development
10.3 Guangzhou Person Pharmaceutical
10.3.1 Guangzhou Person Pharmaceutical Company Information
10.3.2 Guangzhou Person Pharmaceutical Introduction and Business Overview
10.3.3 Guangzhou Person Pharmaceutical Vinblastinesulphate Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Guangzhou Person Pharmaceutical Vinblastinesulphate Products Offered
10.3.5 Guangzhou Person Pharmaceutical Recent Development
10.4 Hainan Yueyang Biotechnology
10.4.1 Hainan Yueyang Biotechnology Company Information
10.4.2 Hainan Yueyang Biotechnology Introduction and Business Overview
10.4.3 Hainan Yueyang Biotechnology Vinblastinesulphate Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Hainan Yueyang Biotechnology Vinblastinesulphate Products Offered
10.4.5 Hainan Yueyang Biotechnology Recent Development
10.5 Hubei Honch Pharmaceutical
10.5.1 Hubei Honch Pharmaceutical Company Information
10.5.2 Hubei Honch Pharmaceutical Introduction and Business Overview
10.5.3 Hubei Honch Pharmaceutical Vinblastinesulphate Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Hubei Honch Pharmaceutical Vinblastinesulphate Products Offered
10.5.5 Hubei Honch Pharmaceutical Recent Development
10.6 Fine Chemicals Corporation
10.6.1 Fine Chemicals Corporation Company Information
10.6.2 Fine Chemicals Corporation Introduction and Business Overview
10.6.3 Fine Chemicals Corporation Vinblastinesulphate Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Fine Chemicals Corporation Vinblastinesulphate Products Offered
10.6.5 Fine Chemicals Corporation Recent Development
10.7 Hengtengfu Biological Products
10.7.1 Hengtengfu Biological Products Company Information
10.7.2 Hengtengfu Biological Products Introduction and Business Overview
10.7.3 Hengtengfu Biological Products Vinblastinesulphate Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Hengtengfu Biological Products Vinblastinesulphate Products Offered
10.7.5 Hengtengfu Biological Products Recent Development
10.8 Vinkem
10.8.1 Vinkem Company Information
10.8.2 Vinkem Introduction and Business Overview
10.8.3 Vinkem Vinblastinesulphate Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Vinkem Vinblastinesulphate Products Offered
10.8.5 Vinkem Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Vinblastinesulphate Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Vinblastinesulphate Industrial Chain Analysis
11.4 Vinblastinesulphate Market Dynamics
11.4.1 Vinblastinesulphate Industry Trends
11.4.2 Vinblastinesulphate Market Drivers
11.4.3 Vinblastinesulphate Market Challenges
11.4.4 Vinblastinesulphate Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Vinblastinesulphate Distributors
12.3 Vinblastinesulphate Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
